Stratos Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.7M Sell
121,547
-1,693
-1% -$394K 0.34% 54
2025
Q4
$25.5M Sell
123,240
-1,880
-2% -$372K 0.29% 69
2025
Q3
$23.2M Buy
125,120
+19,206
+18% +$3.29M 0.27% 72
2025
Q2
$16.2M Sell
105,914
-2,588
-2% -$398K 0.22% 95
2025
Q1
$18M Sell
108,502
-9,248
-8% -$1.45M 0.27% 73
2024
Q4
$17M Sell
117,750
-2,479
-2% -$384K 0.24% 83
2024
Q3
$19.5M Buy
120,229
+4,260
+4% +$679K 0.28% 71
2024
Q2
$17M Sell
115,969
-3,033
-3% -$451K 0.27% 73
2024
Q1
$18.8M Buy
119,002
+747
+0.6% +$119K 0.31% 62
2023
Q4
$18.5M Sell
118,255
-4,544
-4% -$697K 0.35% 49
2023
Q3
$19.1M Buy
122,799
+3,947
+3% +$651K 0.41% 42
2023
Q2
$19.7M Sell
118,852
-8,541
-7% -$1.38M 0.45% 41
2023
Q1
$19.7M Sell
127,393
-17,358
-12% -$2.8M 0.53% 33
2022
Q4
$25.6M Buy
144,751
+1,836
+1% +$317K 0.65% 25
2022
Q3
$23.3M Sell
142,915
-8,025
-5% -$1.36M 0.65% 25
2022
Q2
$26.8M Buy
150,940
+6,721
+5% +$1.2M 0.68% 27
2022
Q1
$25.6M Sell
144,219
-1,296
-0.9% -$221K 0.57% 27
2021
Q4
$24.9M Sell
145,515
-1,905
-1% -$312K 0.55% 29
2021
Q3
$23.8M Buy
147,420
+328
+0.2% +$56K 0.61% 26
2021
Q2
$24.2M Buy
147,092
+7,813
+6% +$1.29M 0.6% 27
2021
Q1
$22.9M Buy
139,279
+1,280
+0.9% +$207K 0.63% 26
2020
Q4
$21.7M Sell
137,999
-6,701
-5% -$989K 0.64% 23
2020
Q3
$21.5M Buy
144,700
+1,600
+1% +$237K 0.71% 20
2020
Q2
$20.1M Buy
143,100
+8,437
+6% +$1.23M 0.72% 21
2020
Q1
$17.7M Buy
134,663
+1,281
+1% +$182K 0.81% 17
2019
Q4
$19.5M Sell
133,382
-2,196
-2% -$298K 0.76% 18
2019
Q3
$17.5M Sell
135,578
-229
-0.2% -$30.2K 0.76% 17
2019
Q2
$18.9M Buy
135,807
+1,282
+1% +$177K 0.82% 17
2019
Q1
$18.8M Sell
134,525
-1,390
-1% -$186K 0.85% 16
2018
Q4
$17.5M Sell
135,915
-8,871
-6% -$1.24M 0.9% 15
2018
Q3
$20M Buy
144,786
+6,161
+4% +$819K 0.89% 15
2018
Q2
$16.8M Buy
138,625
+22,801
+20% +$2.84M 0.75% 22
2018
Q1
$14.8M Buy
115,824
+6,320
+6% +$854K 0.63% 25
2017
Q4
$15.3M Sell
109,504
-1,388
-1% -$193K 0.69% 25
2017
Q3
$14.4M Sell
110,892
-10,941
-9% -$1.45M 0.68% 26
2017
Q2
$16.1M Buy
121,833
+4,378
+4% +$558K 0.83% 23
2017
Q1
$14.6M Buy
117,455
+12,841
+12% +$1.53M 0.83% 24
2016
Q4
$12.1M Buy
104,614
+2,747
+3% +$317K 0.75% 26
2016
Q3
$12M Buy
101,867
+9,935
+11% +$1.21M 0.81% 26
2016
Q2
$11.2M Buy
91,932
+17,065
+23% +$1.94M 0.83% 27
2016
Q1
$8.1M Buy
74,867
+12,116
+19% +$1.25M 0.69% 31
2015
Q4
$6.45M Sell
62,751
-1,201
-2% -$121K 0.54% 36
2015
Q3
$5.97M Buy
63,952
+4,249
+7% +$411K 0.75% 23
2015
Q2
$5.82M Sell
59,703
-7,901
-12% -$791K 0.75% 21
2015
Q1
$6.8M Buy
67,604
+10,131
+18% +$1.03M 0.81% 21
2014
Q4
$6.01M Buy
57,473
+1,967
+4% +$207K 1.08% 14
2014
Q3
$5.92M Buy
55,506
+8,832
+19% +$916K 1.39% 14
2014
Q2
$4.87M Buy
+46,674
New +$4.72M 1.63% 5

Other funds holding JNJ

Stratos Wealth Partners's JNJ Position: Q1 2026 in Review

Stratos Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q1 2026, selling an estimated $394K and leaving 121,547 shares worth $29.7M. The position accounts for 0.34% of the portfolio, ranked #54.

Stratos Wealth Partners first reported a position in JNJ in Q2 2014 and has held it in 48 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Stratos Wealth Partners held 121,547 shares of Johnson & Johnson worth $29.7M as of Q1 2026.
  • Stratos Wealth Partners sold 1,693 Johnson & Johnson shares in Q1 2026, an estimated $394K.
  • Johnson & Johnson made up 0.34% of Stratos Wealth Partners's portfolio in Q1 2026, its #54 holding.
  • Stratos Wealth Partners first reported a position in Johnson & Johnson in Q2 2014 and has held it in 48 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.